IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial
Sheng-Li Xue, Mei-Jing Liu, Chong-Sheng Qian, Su-Ning Chen, Hui-Ying Qiu, Li-Qing Kang, Hai-Ping Dai, Wen-Jie Gong, Li-Yun Chen, Zhen Yao, Ming-Zhu Xu, Hai-Xia Zhou, Xiao-Fei Yang, Qian Wu, Xue-Qing Dou, Jian Zhang, Yin Liu, Qing-Ya Cui, Zheng Li, Yang Xu, Man Qiao
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCAR-T cell therapy research · Virus-based gene therapy research · Viral Infectious Diseases and Gene Expression in Insects